REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,000 | +94.4% | 539 | -58.0% | 0.00% | – |
| Q2 2022 | $18,000 | -28.0% | 1,283 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | +19.0% | 1,283 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -41.7% | 1,283 | 0.0% | 0.00% | – |
| Q3 2021 | $36,000 | -5.3% | 1,283 | 0.0% | 0.00% | – |
| Q2 2021 | $38,000 | +5.6% | 1,283 | 0.0% | 0.00% | – |
| Q1 2021 | $36,000 | -21.7% | 1,283 | -21.6% | 0.00% | – |
| Q4 2020 | $46,000 | +12.2% | 1,636 | 0.0% | 0.00% | – |
| Q3 2020 | $41,000 | +2.5% | 1,636 | 0.0% | 0.00% | – |
| Q2 2020 | $40,000 | -65.5% | 1,636 | -72.7% | 0.00% | – |
| Q3 2014 | $116,000 | -43.1% | 6,000 | 0.0% | 0.00% | – |
| Q2 2014 | $204,000 | +23.6% | 6,000 | +14.3% | 0.00% | – |
| Q1 2014 | $165,000 | – | 5,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |